# Ribonaut Therapeutics, Inc. — Form D

Ribonaut Therapeutics, Inc. of JUPITER, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-04. The offering totals $26.0M, of which $6.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-01-04
- Form: D
- Accession: 0001956680-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.0M
- Amount sold: $6.9M
- Remaining: $19.1M
- Investors: 6
- Date of first sale: 2022-11-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469691

## Issuer

- Name: Ribonaut Therapeutics, Inc.
- CIK: 0001956680
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 492 PEACOCK LN N, JUPITER, FL, 33458
- Phone: 716-380-7737

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Disney | Director | JUPITER, FL |
| LUSONG LUO | Director | PITTSBURGH, PA |
| Steven Tregay | Director | JUPITER, FL |
| Zachary Collins | Executive Officer | Holland, MI |
| Matthew Disney | Executive Officer | JUPITER, FL |
| Jessica Childs-Disney | Promoter | JUPITER, FL |

## More

- [CIK 1956680 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1956680&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001956680-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.